Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics
James H. Finke, Pat Rayman, Jennifer S. Ko, et al.
The Cancer Journal (2013) Vol. 19, Iss. 4, pp. 353-364
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types
Michael D. Iglesia, Joel S. Parker, Katherine A. Hoadley, et al.
JNCI Journal of the National Cancer Institute (2016) Vol. 108, Iss. 11, pp. djw144-djw144
Open Access | Times Cited: 317
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma
Revati Sharma, Elif Kadife, Mark A. Myers, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 114
Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
Juan Jin, Yuhao Xie, Jin-Shi Zhang, et al.
Drug Resistance Updates (2023) Vol. 67, pp. 100929-100929
Open Access | Times Cited: 84
Complex role for the immune system in initiation and progression of pancreatic cancer
Kristin S. Inman
World Journal of Gastroenterology (2014) Vol. 20, Iss. 32, pp. 11160-11160
Open Access | Times Cited: 126
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease
Karen M. Dwyer, Bellamkonda Kishore, Simon C. Robson
Nature Reviews Nephrology (2020) Vol. 16, Iss. 9, pp. 509-524
Closed Access | Times Cited: 102
An unexpected increase of toxicity of amino acid-containing ionic liquids
Ksenia S. Egorova, Marina M. Seitkalieva, Alexandra V. Posvyatenko, et al.
Toxicology Research (2014) Vol. 4, Iss. 1, pp. 152-159
Open Access | Times Cited: 83
Adoptive T-Cell Therapy for Solid Tumors
Oladapo O. Yeku, Xinghuo Li, Renier J. Brentjens
American Society of Clinical Oncology Educational Book (2017), Iss. 37, pp. 193-204
Open Access | Times Cited: 74
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction
Margherita Gigante, Paola Pontrelli, Wolfgang Herr, et al.
Journal of Translational Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 63
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Antonella Argentiero, Antonio Giovanni Solimando, Markus Krebs, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1594-1594
Open Access | Times Cited: 61
The immune response in cancer: from immunology to pathology to immunotherapy
Nicolás A. Giraldo, Étienne Becht, Yann Vano, et al.
Virchows Archiv (2015) Vol. 467, Iss. 2, pp. 127-135
Closed Access | Times Cited: 54
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
C. F. Chang, Yao‐Hsu Yang, Chiao‐Juno Chiu, et al.
International Journal of Cancer (2017) Vol. 142, Iss. 9, pp. 1878-1889
Open Access | Times Cited: 54
Current Status and Future Directions of Immunotherapy in Renal Cell Carcinoma
Bryden Considine, Michael E. Hurwitz
Current Oncology Reports (2019) Vol. 21, Iss. 4
Closed Access | Times Cited: 44
The tumor microenvironment in renal cell cancer
James W. Mier
Current Opinion in Oncology (2019) Vol. 31, Iss. 3, pp. 194-199
Open Access | Times Cited: 43
Modification of Antitumor Immunity and Tumor Microenvironment by Resveratrol in Mouse Renal Tumor Model
Liang Chen, Sixing Yang, Wenbiao Liao, et al.
Cell Biochemistry and Biophysics (2015) Vol. 72, Iss. 2, pp. 617-625
Closed Access | Times Cited: 46
Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?
Alessia Mennitto, Veronica Huber, Raffaele Ratta, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 930-930
Open Access | Times Cited: 35
Clinical applications of PD-1-based therapy: a focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types
April K.S. Salama, Tara C. Gangadhar
OncoTargets and Therapy (2015), pp. 929-929
Open Access | Times Cited: 38
The blockage of Notch signalling promoted the generation of polymorphonuclear myeloid-derived suppressor cells with lower immunosuppression
Shuhong Wang, Qingyang Lu, Yahuan Guo, et al.
European Journal of Cancer (2016) Vol. 68, pp. 90-105
Closed Access | Times Cited: 35
Toward Normalization of the Tumor Microenvironment for Cancer Therapy
Jie Zheng, Peng Gao
Integrative Cancer Therapies (2019) Vol. 18
Open Access | Times Cited: 34
<p>Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date</p>
Vincent Chau, Marijo Bilušić
Cancer Management and Research (2020) Vol. Volume 12, pp. 7321-7330
Open Access | Times Cited: 31
Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation
J. Pablo Arnoletti, Xiang Zhu, Alvin J.O. Almodovar, et al.
Pancreas (2016) Vol. 46, Iss. 1, pp. 116-123
Closed Access | Times Cited: 31
Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo
Melek M. E. Sunay, Jeremy B. Foote, James M. Leatherman, et al.
International Immunopharmacology (2017) Vol. 46, pp. 112-123
Open Access | Times Cited: 31
Tumor-educated B cells promote renal cancer metastasis via inducing the IL-1β/HIF-2α/Notch1 signals
Saiyang Li, Chi Huang, Guanghui Hu, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 3
Open Access | Times Cited: 26
Adoptive T-Cell Therapy for Solid Tumors
Oladapo O. Yeku, Xinghuo Li, Renier J. Brentjens
American Society of Clinical Oncology Educational Book (2017) Vol. 37, pp. 193-204
Open Access | Times Cited: 28
Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma
Xingming Zhang, Xiaoxue Yin, Haoran Zhang, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 24
Tumour and patient factors in renal cell carcinoma—towards personalized therapy
Ahmed Haddad, Vitaly Margulis
Nature Reviews Urology (2015) Vol. 12, Iss. 5, pp. 253-262
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top